Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist.
J Neurointerv Surg
; 13(3): 202-206, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-970181
ABSTRACT
Coronavirus disease 2019 (COVID-19) results from infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first reported in Wuhan, China in patients suffering from severe pneumonia and acute respiratory distress syndrome and has now grown into the first pandemic in over 100 years. Patients infected with SARS-CoV-2 develop arterial thrombosis including stroke, myocardial infarction and peripheral arterial thrombosis, all of which result in poor outcomes despite maximal medical, endovascular, and microsurgical treatment compared with non-COVID-19-infected patients. In this review we provide a brief overview of SARS-CoV-2, the infectious agent responsible for the COVID-19 pandemic, and describe the mechanisms responsible for COVID-19-associated coagulopathy. Finally, we discuss the impact of COVID-19 on ischemic stroke, focusing on large vessel occlusion.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombosis
/
Thrombolytic Therapy
/
Brain Ischemia
/
Ischemic Stroke
/
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
J Neurointerv Surg
Year:
2021
Document Type:
Article
Affiliation country:
Neurintsurg-2020-016794
Similar
MEDLINE
...
LILACS
LIS